Charles Ornstein & Katie Thomas
Charles Ornstein is a senior reporter for ProPublica covering health care and the pharmaceutical industry.
Charles Ornstein is a senior reporter for ProPublica covering health care and the pharmaceutical industry.
It seems that overall drug spending is still on the rise because of the skyrocketing price of new, brand-name drugs.
Out of public view, corporations are cutting deals that give consumers little choice but to buy brand-name drugsāand sometimes pay more at the pharmacy counter than they would for generics.
Drugmakers are increasingly agreeing to refund money if patients don't respond to medications as expected.